About John

Dr. John Ward is Director of the Division of Viral Hepatitis at the Centers for Disease Control and Prevention (CDC). During his tenure, Dr. Ward has guided development of national viral hepatitis surveillance, prevention research, policies and programs including those to promote education, vaccination, and testing with linkage to care and treatment. Dr. Ward initiated two Institute of Medicine (IOM) reviews of viral hepatitis prevention in the United States, and authored the first Action Plan for Viral Hepatitis Prevention, Care, and Treatment for the United States. Globally, Dr. Ward serves as an expert consultant to the World Health Organization, other international organizations and national ministries of health.  Dr. Ward’s experience includes 14 years in the field of HIV/AIDS conducting early studies of HIV transmission, natural history and directing national HIV/AIDS surveillance. Dr. Ward has authored over 150 scientific publications, served as Editor of CDC’s Morbidity and Mortality Weekly Report (MMWR), and served as Editor for Silent Victories, a history of public health in the 20th century published in 2007 by Oxford University Press.  Dr. Ward received his MD degree from the University of Alabama School of Medicine in Birmingham and completed an internship and residency in internal medicine at the University of Alabama Hospitals. He holds a clinical faculty appointment with the Department of Medicine, Emory University, Atlanta, GA.

This speaker will be presenting at the following session(s)

  • Strategic direction 2: interventions for impact and strategic direction 3: delivering for equity

    Golden Hall

    Day: 2 November

    Time: 09:15

    The second day of the Summit is dedicated to strategic directions 2 and 3, which cover the issues of "interventions for impact" and "delivering for equity".

    Chairs: Dr. Florence Zeh Kakanou, Ministry of Public Health, Cameroon and Dr. Saeed Hamid, The Aga Khan University, Pakistan


    • 5 core interventions to reach HBV and HCV elimination.
      Dr. Hande Harmanci, World Health Organization
    • Scaling-up of treatment services in Brazil.
      Dr. Adele Benzaken, Ministry of Health, Brazil
    • Hepatitis B services – challenges and opportunities.
      Dr. Chukwuma Anyaike, Federal Ministry of Health, Nigeria
    • Continuum of interventions to prevent HBV infection at birth and in the first years of life
    • Dr. John Ward, US Centers for Disease Control and Prevention
    • Hepatitis C prevention and treatment for PWID.
      Prof. Gregory Dore, Kirby Institute, UNSW Sydney and St Vincent’s Hospital, Sydney
    • Hepatitis services for indigenous people.
      Luana Silveira de Faria, Ministry of Health, Brazil
    • Q & A session.

    Session objectives:

    • Learn areas of innovation and neglected issues.
    • Hear about the core issues for elimination and equitable access.
    • Gain an overview of the main advocacy areas and gaps.